{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:26:25Z","timestamp":1791897985304,"version":"4.3.4"},"reference-count":48,"publisher":"American Society of Hematology","issue":"3","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,13]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>To clarify the different characteristics and prognostic factors of cord blood transplantation (CBT) in adult patients with lymphoid neoplasms in Europe and Japan, we conducted a collaborative study. Patients aged 18-75 years receiving their first CBT (Europe: single CBT, n\u00a0= 192; double CBT, n\u00a0= 304; Japan: single CBT, n\u00a0= 1150) in 2000-2017 were analyzed. Fewer patients with Hodgkin lymphoma (Europe vs Japan, 26% vs 5%), and older patients (\u226550 years) (39% vs 59%) with a higher refined disease risk index (rDRI) (high-very high: 49% vs 14%) were included in the Japanese registry. High-very high rDRI was associated with inferior overall survival (OS)\u00a0(vs low rDRI, Europe: hazard ratio [HR], 1.87;\u00a0P\u00a0= .001; Japan: HR, 2.34;\u00a0P\u00a0&amp;lt; .001) with higher progression\/relapse risks. Total body irradiation (TBI)\u2013containing conditioning contributed to superior OS both in Europe (vs TBI\u2013reduced-intensity conditioning [RIC], non-TBI-RIC: HR, 1.93;\u00a0P\u00a0&amp;lt; .001; non-TBI\u2013Myeloablative conditioning [MAC]: HR, 1.90;\u00a0P\u00a0=\u00a0.003) and Japan (non\u2013TBI-RIC: HR, 1.71;\u00a0P\u00a0&amp;lt;\u00a0.001; non\u2013TBI-MAC: HR 1.50,\u00a0P\u00a0= .007). The impact of HLA mismatches (\u22652) on OS differed (Europe: HR, 1.52;\u00a0P\u00a0= .007; Japan: HR, 1.18;\u00a0P\u00a0= .107). CBT for lymphoid neoplasms, especially in those with high rDRI showed poor outcomes despite all the different characteristics in both registries. TBI should be considered in conditioning regimens to improve these outcomes. The different impacts of HLA mismatches call attention to the fundamental differences among these populations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023010598","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T18:23:20Z","timestamp":1702664600000},"page":"640-652","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4030-4653","authenticated-orcid":false,"given":"Mizuki","family":"Watanabe","sequence":"first","affiliation":[{"name":"1Department of Hematology, Kyoto University Hospital, Kyoto, Japan"},{"name":"2Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Kyoto University Hospital, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Volt","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"4Haematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-7614","authenticated-orcid":false,"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"5Department of Oncology\/Hematology, Shimane University School of Medicine, Izumo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanadi","family":"Rafii","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-9904","authenticated-orcid":false,"given":"Fumihiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"6Division of Hematology, National Defense Medical College, Tokorozawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cappelli","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"7Monacord, Centre Scientifique de Monaco, Monaco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-9405","authenticated-orcid":false,"given":"Eisei","family":"Kondo","sequence":"additional","affiliation":[{"name":"8Department of Hematology, Kawasaki Medical School, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana Maria","family":"Scigliuolo","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"7Monacord, Centre Scientifique de Monaco, Monaco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"9Division of Molecular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Kenzey","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Rivera-Franco","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-4152","authenticated-orcid":false,"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[{"name":"10Division of Hematology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"11Service of Hematology, Transfusion and Cell Therapy, and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Cl\u00ednicas, Faculty of Medicine, S\u00e3o Paulo University, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[{"name":"12Department D'Hematologie, Centre Hospitalier Universitaire de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-4619","authenticated-orcid":false,"given":"Jaime","family":"Sanz","sequence":"additional","affiliation":[{"name":"13Department of Hematology, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"F\u00fcrst","sequence":"additional","affiliation":[{"name":"14Department of Hematology, Institut Paoli Calmettes, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cornelissen","sequence":"additional","affiliation":[{"name":"15Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Milpied","sequence":"additional","affiliation":[{"name":"16Service d'H\u00e9matologie Clinique et Th\u00e9rapie Cellulaire, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"17Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Sugio","sequence":"additional","affiliation":[{"name":"18Department of Hematology, Kitakyusyu City Hospital Organization, Kitakyusyu Municipal Medical Center, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"19Preparation Department, Japanese Red Cross Kinki Block Blood Center, Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-4066","authenticated-orcid":false,"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[{"name":"20Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[{"name":"2Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"21Department of Hematology, Hopital Saint Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Peffault de Latour","sequence":"additional","affiliation":[{"name":"22Department of Hematology, Hopital Saint Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[{"name":"23Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan"},{"name":"24Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Gluckman","sequence":"additional","affiliation":[{"name":"3Eurocord, Hopital Saint Louis, Assistance Publique - Hopitaux de Paris, Institut de Recherche de Saint-Louis EA3518, Universit\u00e9 de Paris Cit\u00e9, Paris, France"},{"name":"7Monacord, Centre Scientifique de Monaco, Monaco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,1,26]]},"reference":[{"key":"2024021217051531400_bib1","doi-asserted-by":"crossref","first-page":"963689720964771","DOI":"10.1177\/0963689720964771","article-title":"Haploidentical hematopoietic stem cell transplantation versus umbilical cord blood transplantation in hematologic malignancies: a systematic review and meta-analysis","volume":"29","author":"Wu","year":"2020","journal-title":"Cell Transplant"},{"issue":"2","key":"2024021217051531400_bib2","doi-asserted-by":"crossref","first-page":"109.e1","DOI":"10.1016\/j.jtct.2021.11.002","article-title":"Umbilical cord blood or HLA-haploidentical transplantation: real-world outcomes versus randomized trial outcomes","volume":"28","author":"O\u2019Donnell","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"2024021217051531400_bib3","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2015.98","article-title":"Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia","volume":"29","author":"Ruggeri","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"2024021217051531400_bib4","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1016\/j.bbmt.2019.12.566","article-title":"Comparison of haploidentical related donor with post-transplant cyclophosphamide (PTCy) and umbilical cord blood (UCB) transplantation after myeloablative conditioning for hematological malignancy","volume":"26","author":"Wagner","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2024021217051531400_bib5","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41409-021-01426-3","article-title":"Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Therapie Cellulaire","volume":"56","author":"Cornillon","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2024021217051531400_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs","year":"2021","journal-title":"Blood"},{"issue":"1","key":"2024021217051531400_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41375-019-0534-5","article-title":"Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord\/ALWP-EBMT and JSHCT\/JDCHCT collaborative study","volume":"34","author":"Kanda","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"2024021217051531400_bib8","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2024021217051531400_bib9","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"issue":"3","key":"2024021217051531400_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2024021217051531400_bib11","first-page":"695","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"706","author":"Storer","year":"1999","journal-title":""},{"issue":"446","key":"2024021217051531400_bib12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"3","key":"2024021217051531400_bib13","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2024021217051531400_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"25","key":"2024021217051531400_bib15","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"2024021217051531400_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.13802","article-title":"Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols","volume":"172","author":"Hough","year":"2016","journal-title":"Br J Haematol"},{"issue":"12","key":"2024021217051531400_bib17","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.bbmt.2020.07.030","article-title":"Guidelines for cord blood unit selection","volume":"26","author":"Politikos","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2024021217051531400_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.coi.2006.07.014","article-title":"Donor selection for unrelated cord blood transplants","volume":"18","author":"Gluckman","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"2024021217051531400_bib19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/s41409-019-0539-8","article-title":"Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience","volume":"54","author":"Yanada","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2024021217051531400_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bbmt.2017.03.036","article-title":"Cryopreserved CD34\u00a0+ cell dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients","volume":"23","author":"Konuma","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2024021217051531400_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjh.15418","article-title":"Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD 34-positive cells or total nucleated cells?","volume":"185","author":"Nakasone","year":"2019","journal-title":"Br J Haematol"},{"issue":"9","key":"2024021217051531400_bib22","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2009-07-231068","article-title":"Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies","volume":"115","author":"Barker","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2024021217051531400_bib23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3324\/haematol.2012.076042","article-title":"Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia","volume":"98","author":"Atsuta","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"2024021217051531400_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/blood-2013-05-506253","article-title":"Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy","volume":"123","author":"Eapen","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2024021217051531400_bib25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bbmt.2019.11.001","article-title":"Impact of HLA allele mismatch at HLA-A, -B, -C, and -DRB1 in single cord blood transplantation","volume":"26","author":"Yokoyama","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2024021217051531400_bib26","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.bbmt.2018.07.019","article-title":"Outcomes of advanced Hodgkin lymphoma after umbilical cord blood transplantation: a Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study","volume":"24","author":"Paviglianiti","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2024021217051531400_bib27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3324\/haematol.2012.080895","article-title":"Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin\u2019s lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"98","author":"Marcais","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"2024021217051531400_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.25705","article-title":"Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017","volume":"95","author":"Konuma","year":"2020","journal-title":"Am J Hematol"},{"issue":"11","key":"2024021217051531400_bib29","doi-asserted-by":"crossref","first-page":"777.e1","DOI":"10.1016\/j.jtct.2022.08.006","article-title":"Reducing mortality of single-unit unrelated cord blood transplantation for relapsed acute myeloid leukemia after a previous allogeneic transplantation: a real-world retrospective study over the past 19 years in Japan","volume":"28","author":"Konuma","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"2024021217051531400_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41408-022-00678-6","article-title":"Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia","volume":"12","author":"Konuma","year":"2022","journal-title":"Blood Cancer J"},{"issue":"19","key":"2024021217051531400_bib31","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","article-title":"Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors","volume":"31","author":"Hahn","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"2024021217051531400_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2141.2009.07883.x","article-title":"Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors","volume":"147","author":"Rocha","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"2024021217051531400_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41409-021-01479-4","article-title":"The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations","volume":"57","author":"Kanda","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2024021217051531400_bib34","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","article-title":"Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study","volume":"119","author":"Kanda","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2024021217051531400_bib35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/joim.12696","article-title":"Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT","volume":"283","author":"Baron","year":"2018","journal-title":"J\u00a0Intern Med"},{"issue":"22","key":"2024021217051531400_bib36","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1182\/blood.V128.22.3491.3491","article-title":"Impact of human leukocyte antigen (HLA) alleles on outcomes of allogeneic transplantation (Allo-HCT) for B-cell non-Hodgkin lymphomas (B-NHL); a CIBMTR analysis","volume":"128","author":"William","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2024021217051531400_bib37","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bbmt.2012.02.011","article-title":"HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies","volume":"18","author":"Battiwalla","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"2024021217051531400_bib38","doi-asserted-by":"crossref","first-page":"27645","DOI":"10.18632\/oncotarget.15291","article-title":"Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis","volume":"8","author":"Tie","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"2024021217051531400_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol"},{"issue":"9","key":"2024021217051531400_bib40","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/bmt.2017.96","article-title":"Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8\/8 matched unrelated donor hematopoietic cell transplantation","volume":"52","author":"Fleischhauer","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"2024021217051531400_bib41","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1182\/bloodadvances.2020003371","article-title":"High progression-free survival after intermediate intensity double unit cord blood transplantation in adults","volume":"4","author":"Barker","year":"2020","journal-title":"Blood Adv"},{"issue":"14","key":"2024021217051531400_bib42","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/bloodadvances.2020002222","article-title":"Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter study","volume":"4","author":"Milano","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2024021217051531400_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1182\/hematology.2019000056","article-title":"Optimizing Cord Blood Selection","author":"Ruggeri","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"10","key":"2024021217051531400_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jtct.2023.07.022","article-title":"Selection of cord blood unit by CD34+ cell and GM-CFU numbers and allele-level HLA matching in single cord blood transplantation","volume":"29","author":"Morishima","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"2024021217051531400_bib45","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jtct.2020.11.008","article-title":"Guidelines for adult patient selection and conditioning regimens in cord blood transplant recipients with hematologic malignancies and aplastic anemia","volume":"27","author":"Metheny","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"2024021217051531400_bib46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jtct.2021.03.012","article-title":"Guidelines for the prevention and management of graft-versus-host disease after cord blood transplantation","volume":"27","author":"Ponce","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"2024021217051531400_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.24613","article-title":"Impact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation","volume":"92","author":"Nakasone","year":"2017","journal-title":"Am J Hematol"},{"issue":"12","key":"2024021217051531400_bib48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/640\/2212869\/blooda_adv-2023-010598-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/3\/640\/2212869\/blooda_adv-2023-010598-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T17:06:29Z","timestamp":1707757589000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/3\/640\/506630\/Cord-blood-transplantation-for-adult-mature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010598","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,26]]}}}